Literature DB >> 30753829

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.

Matthew D Hellmann, Margaret K Callahan, Mark M Awad, Emiliano Calvo, Paolo A Ascierto, Akin Atmaca, Naiyer A Rizvi, Fred R Hirsch, Giovanni Selvaggi, Joseph D Szustakowski, Ariella Sasson, Ryan Golhar, Patrik Vitazka, Han Chang, William J Geese, Scott J Antonia.   

Abstract

Entities:  

Year:  2019        PMID: 30753829     DOI: 10.1016/j.ccell.2019.01.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  34 in total

Review 1.  Small-cell lung cancer.

Authors:  Charles M Rudin; Elisabeth Brambilla; Corinne Faivre-Finn; Julien Sage
Journal:  Nat Rev Dis Primers       Date:  2021-01-14       Impact factor: 52.329

Review 2.  Predictive biomarkers of response to immune checkpoint inhibitors in melanoma.

Authors:  Caroline A Nebhan; Douglas B Johnson
Journal:  Expert Rev Anticancer Ther       Date:  2020-02-05       Impact factor: 4.512

3.  Pan-cancer analysis of tumor mutation burden sensitive tumors reveals tumor-specific subtypes and hub genes related to immune infiltration.

Authors:  Huan Wu; Hanchu Wang; Yue Chen
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-02       Impact factor: 4.553

Review 4.  Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective.

Authors:  Harleen Kaur Walia; Parul Sharma; Navneet Singh; Siddharth Sharma
Journal:  Curr Treat Options Oncol       Date:  2022-02-28

5.  Genomics-based immuno-oncology: bridging the gap between immunology and tumor biology.

Authors:  Renzo G DiNatale; A Ari Hakimi; Timothy A Chan
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

6.  Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis.

Authors:  Zimu Wang; Ping Zhan; Yanling Lv; Kaikai Shen; Yuqing Wei; Hongbing Liu; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2019-06

7.  Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity.

Authors:  Navin R Mahadevan; Erik H Knelson; Jacquelyn O Wolff; Amir Vajdi; Maria Saigí; Marco Campisi; Deli Hong; Tran C Thai; Brandon Piel; Saemi Han; Bruce B Reinhold; Jonathan S Duke-Cohan; Michael J Poitras; Luke J Taus; Patrick H Lizotte; Andrew Portell; Victor Quadros; Alison D Santucci; Takahiko Murayama; Israel Cañadas; Shunsuke Kitajima; Aoi Akitsu; Maya Fridrikh; Hideo Watanabe; Brendan Reardon; Prafulla C Gokhale; Cloud P Paweletz; Mark M Awad; Eliezer M Van Allen; Ana Lako; Xi-Tao Wang; Benjamin Chen; Fangxin Hong; Lynette M Sholl; Michael Y Tolstorukov; Kathleen Pfaff; Pasi A Jänne; Evisa Gjini; Robin Edwards; Scott Rodig; Ellis L Reinherz; Matthew G Oser; David A Barbie
Journal:  Cancer Discov       Date:  2021-03-11       Impact factor: 39.397

8.  Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC.

Authors:  Zhimin Zhang; Yanyan Gu; Xiaona Su; Jing Bai; Wei Guan; Jungang Ma; Jia Luo; Juan He; Bicheng Zhang; Mingying Geng; Xuefeng Xia; Yanfang Guan; Cheng Shen; Chuan Chen
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

9.  Immune checkpoint inhibitors for treatment of small-cell lung cancer: a systematic review and meta-analysis.

Authors:  Zhicheng Niu; Shenghu Guo; Jing Cao; Yuehua Zhang; Xiaojin Guo; Francesco Grossi; Yoshinobu Ichiki; You Li; Zhiyu Wang
Journal:  Ann Transl Med       Date:  2021-04

Review 10.  Current status and future perspectives of immunotherapy in bladder cancer treatment.

Authors:  Zhangsong Wu; Jinjian Liu; Ruixiang Dai; Song Wu
Journal:  Sci China Life Sci       Date:  2020-08-26       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.